In a landmark decision from the FDA, genomics firm 23andMe's direct-to-consumer genetics test has been approved in 10 conditions. Originally given FDA marketing authorisation in February 2015 as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback